BACKGROUND AND OBJECTIVES: Vitamin D deficiency causes muscle weakness, impairs bone formation and neuromuscular coordination thus leading to an increase in fracture risk. It has been found that inadequate levels of vitamin D are present in most of the osteoporosis patients. However, very few studies investigate the association between vitamin D status and quality of life (QOL). The aim of this study is to investigate the effects of vitamin D on QOL among Turkish women with osteoporosis. METHODS: 259 patients (61.0 +/- 8.9 years) with osteoporosis were evaluated by physical activity level, back pain, bone turnover markers, 25-hydroxyvitamin D [25(OH)D], parathyroid hormone levels and bone mineral density. QOL was assessed using QOL Questionnaire of the European Foundation for Osteoporosis (QUALEFFO). 25(OH)D levels below 20 ng/ml was defined as vitamin D insufficiency, below 12 ng/ml as vitamin D deficiency. RESULTS: Mean 25(OH)D level was 22.7 +/- 12.6 ng/ml and mean total QUALEFFO score was 43.3 +/- 14.9. Vitamin D levels were significantly correlated with all subscales and total score of QUALEFFO (r = -0.25, P = 0.0001). Vitamin D insufficiency was determined in 132 patients (51%). In vitamin D deficient (<12 ng/ml) group all subscales and total QOL were found to be poorer when compared with the groups whose vitamin D levels were > or = 12 and <20 ng/ml and > or = 20 ng/ml (effect sizes 0.41 and 0.62 respectively, P = 0.0001 for total QOL). Vitamin D level, education, concomitant diseases, physical activity level and pain severity were found to be significantly associated with QOL in multiple linear regression analysis model. CONCLUSIONS: Vitamin D insufficiency affects physical, social and mental functions of osteoporosis patients and impairs QOL. Vitamin D was found to be one of the factors affecting QOL.
BACKGROUND AND OBJECTIVES:Vitamin D deficiency causes muscle weakness, impairs bone formation and neuromuscular coordination thus leading to an increase in fracture risk. It has been found that inadequate levels of vitamin D are present in most of the osteoporosispatients. However, very few studies investigate the association between vitamin D status and quality of life (QOL). The aim of this study is to investigate the effects of vitamin D on QOL among Turkish women with osteoporosis. METHODS: 259 patients (61.0 +/- 8.9 years) with osteoporosis were evaluated by physical activity level, back pain, bone turnover markers, 25-hydroxyvitamin D [25(OH)D], parathyroid hormone levels and bone mineral density. QOL was assessed using QOL Questionnaire of the European Foundation for Osteoporosis (QUALEFFO). 25(OH)D levels below 20 ng/ml was defined as vitamin Dinsufficiency, below 12 ng/ml as vitamin D deficiency. RESULTS: Mean 25(OH)D level was 22.7 +/- 12.6 ng/ml and mean total QUALEFFO score was 43.3 +/- 14.9. Vitamin D levels were significantly correlated with all subscales and total score of QUALEFFO (r = -0.25, P = 0.0001). Vitamin Dinsufficiency was determined in 132 patients (51%). In vitamin D deficient (<12 ng/ml) group all subscales and total QOL were found to be poorer when compared with the groups whose vitamin D levels were > or = 12 and <20 ng/ml and > or = 20 ng/ml (effect sizes 0.41 and 0.62 respectively, P = 0.0001 for total QOL). Vitamin D level, education, concomitant diseases, physical activity level and pain severity were found to be significantly associated with QOL in multiple linear regression analysis model. CONCLUSIONS:Vitamin Dinsufficiency affects physical, social and mental functions of osteoporosispatients and impairs QOL. Vitamin D was found to be one of the factors affecting QOL.
Authors: P Lips; C Cooper; D Agnusdei; F Caulin; P Egger; O Johnell; J A Kanis; S Kellingray; A Leplege; U A Liberman; E McCloskey; H Minne; J Reeve; J Y Reginster; M Scholz; C Todd; M C de Vernejoul; I Wiklund Journal: Osteoporos Int Date: 1999 Impact factor: 4.507
Authors: Michael F Holick; Ethel S Siris; Neil Binkley; Mary K Beard; Aliya Khan; Jennifer T Katzer; Richard A Petruschke; Erluo Chen; Anne E de Papp Journal: J Clin Endocrinol Metab Date: 2005-03-29 Impact factor: 5.958
Authors: Sarah Motsinger; DeAnn Lazovich; Richard F MacLehose; Carolyn J Torkelson; Kim Robien Journal: Maturitas Date: 2011-12-29 Impact factor: 4.342
Authors: Gregory E Hicks; Michelle Shardell; Ram R Miller; Stefania Bandinelli; Jack Guralnik; Antonio Cherubini; Fulvio Lauretani; Luigi Ferrucci Journal: J Am Geriatr Soc Date: 2008-03-05 Impact factor: 5.562
Authors: H Selimoglu; C Duran; S Kiyici; C Ersoy; M Guclu; G Ozkaya; E Tuncel; E Erturk; S Imamoglu Journal: J Endocrinol Invest Date: 2009-10-09 Impact factor: 4.256
Authors: S Westra; Y H M Krul-Poel; H J van Wijland; M M Ter Wee; F Stam; P Lips; F Pouwer; S Simsek Journal: Endocr Connect Date: 2016-11-01 Impact factor: 3.335